CLEVELAND, Ohio (June 20, 2017)-A new position statement on the use of hormone therapy (HT) for menopausal and postmenopausal women from The North American Menopause Society (NAMS) has been published online today in the Society’s journal, Menopause. “The use of ...

Hot Flashes Could Signal Increased Risk of Heart Disease Study shows younger midlife women with hot flashes more likely to have poor vascular function CLEVELAND, Ohio (April 12, 2017)—Hot flashes, one of the most common symptoms of menopause, have already ...

Weight Loss Actually Possible After Menopause  Study proves effectiveness of exercise in managing weight and hot flashes in postmenopausal women, even those who were previously sedentary  CLEVELAND, Ohio (February 15, 2017)—Talk to a woman in menopause and you’re likely to ...

Low-dose Estrogen Therapy Shown to be Very Effective on Vasomotor Symptoms CLEVELAND, Ohio (Tuesday, October 25, 2016)—For early postmenopausal women concerned about the effectiveness of low-dose estrogen therapy for alleviating menopause symptoms such as hot flashes, night sweats, insomnia, and irritability, data ...

Autumn is the second spring when every leaf is a flower” – Albert Camus Dear Red Hot Mamas, As Hurricane Matthews hammered Florida, the winds and heavy rains enveloped Orlando, Florida where the North American Menopause Society (NAMS) held its ...

Despite Major Consumer Marketing and Educational Efforts, New Survey Shows Women Still Don’t Understand Why Sex Hurts After Menopause Women’s EMPOWER survey confirms reluctance to discuss sex problems and seek treatment  CLEVELAND, Ohio (September 5, 2016)—Unfortunately for many postmenopausal women, ...

Too short or too long reproductive span increases risk of diabetes in postmenopausal women Is there an optimal amount of lifetime estrogen exposure for metabolic functioning? CLEVELAND, Ohio (Wednesday, July 27, 2016)— Using data from the Women’s Health Initiative (WHI), ...

DHEA Improves Vaginal Discomfort After Menopause New phase III trial takes this estrogen alternative a step closer to approval CLEVELAND, Ohio (January 5, 2016)—A new phase III trial with positive results is taking intravaginal DHEA a step closer to governmental ...

Untested, Unapproved Compounded Hormone Prescriptions Reach 26 to 33 Million a Year Despite the risks, the number approaches that for FDA-approved hormone therapies CLEVELAND, Ohio (December 18, 2015)—The number of prescriptions for mostly unregulated compounded hormone therapy for women at ...

After Menopause, Vulvovaginal Troubles Are Common and Linked with Other Pelvic Problems Nevertheless, over 30% of women haven’t seen a gynecologist, and over 80% didn’t get the standard treatment CLEVELAND, Ohio (December 9, 2015)—After menopause, more than half of women ...